167 related articles for article (PubMed ID: 11902527)
1. Prediction of the response of colorectal cancer to systemic therapy.
Adlard JW; Richman SD; Seymour MT; Quirke P
Lancet Oncol; 2002 Feb; 3(2):75-82. PubMed ID: 11902527
[TBL] [Abstract][Full Text] [Related]
2. Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.
McCleary NJ; Meyerhardt JA; Green E; Yothers G; de Gramont A; Van Cutsem E; O'Connell M; Twelves CJ; Saltz LB; Haller DG; Sargent DJ
J Clin Oncol; 2013 Jul; 31(20):2600-6. PubMed ID: 23733765
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for colorectal cancer.
Goyle S; Maraveyas A
Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer: integrating oxaliplatin.
Louvet C; de Gramont A
Curr Treat Options Oncol; 2003 Oct; 4(5):405-11. PubMed ID: 12941200
[TBL] [Abstract][Full Text] [Related]
5. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
6. New developments in systemic chemotherapy in advanced colorectal cancer.
Cats A
Scand J Gastroenterol Suppl; 2003; (239):78-86. PubMed ID: 14743888
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine in combination with irinotecan or oxaliplatin in advanced colorectal cancer.
Clin Colorectal Cancer; 2003 Aug; 3(2):89-91. PubMed ID: 12952563
[No Abstract] [Full Text] [Related]
8. Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters.
Ku GY; Haaland BA; de Lima Lopes G
Cancer Chemother Pharmacol; 2012 Aug; 70(2):231-8. PubMed ID: 22699811
[TBL] [Abstract][Full Text] [Related]
9. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.
Clin Colorectal Cancer; 2003 Feb; 2(4):205-9. PubMed ID: 12620138
[No Abstract] [Full Text] [Related]
10. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
11. Current status of capecitabine in the treatment of colorectal cancer.
Rothenberg ML
Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635
[TBL] [Abstract][Full Text] [Related]
12. [New therapy options in colorectal carcinoma].
Folprecht G; Köhne CH
Ther Umsch; 2004 Jun; 61(6):373-8. PubMed ID: 15253162
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma.
Subbiah IM; Blackmon SH; Correa AM; Kee B; Vaporciyan AA; Swisher SG; Eng C
Oncotarget; 2014 Aug; 5(16):6584-93. PubMed ID: 25051371
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.
Zarate R; Rodríguez J; Bandres E; Patiño-Garcia A; Ponz-Sarvise M; Viudez A; Ramirez N; Bitarte N; Chopitea A; Gacía-Foncillas J
Br J Cancer; 2010 Mar; 102(6):987-94. PubMed ID: 20216541
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.
Santini D; Vincenzi B; La Cesa A; Caricato M; Schiavon G; Spalletta B; Di Seri M; Coppola R; Rocci L; Tonini G
Oncology; 2005; 69(1):27-34. PubMed ID: 16088232
[TBL] [Abstract][Full Text] [Related]
16. [Recent results of irinotecan therapy in colorectal cancer].
Láng I; Hitre E
Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study.
Price TJ; Townsend AR; Khattak A
Ann Oncol; 2010 Oct; 21(10):2121; author reply 2121-2. PubMed ID: 20860991
[No Abstract] [Full Text] [Related]
18. Adjuvant therapy in colon cancer: which treatment in 2005?
Di Costanzo F; Doni L
Ann Oncol; 2005 May; 16 Suppl 4():iv69-73. PubMed ID: 15923433
[No Abstract] [Full Text] [Related]
19. Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.
Bennouna J; Borg C; Delord JP; Husseini F; Trillet-Lenoir V; Faroux R; François E; Ychou M; Goldwasser F; Bouché O; Senellart H; Kraemer S; Douillard JY
Clin Colorectal Cancer; 2012 Mar; 11(1):38-44. PubMed ID: 21803002
[TBL] [Abstract][Full Text] [Related]
20. A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer.
Fornaro L; Masi G; Bursi S; Loupakis F; Vasile E; Antonuzzo A; Chiara S; Pfanner E; Di Paolo A; Bocci G; Del Tacca M; Falcone A
Cancer Chemother Pharmacol; 2009 Apr; 63(5):965-9. PubMed ID: 18839174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
